A detailed history of Wealthfront Advisers LLC transactions in Viatris Inc stock. As of the latest transaction made, Wealthfront Advisers LLC holds 337,334 shares of VTRS stock, worth $4.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
337,334
Previous 308,959 9.18%
Holding current value
$4.18 Million
Previous $3.28 Million 19.24%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.32 - $12.13 $292,830 - $344,188
28,375 Added 9.18%
337,334 $3.92 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $364,402 - $435,833
36,259 Added 13.3%
308,959 $3.28 Million
Q1 2024

Apr 19, 2024

BUY
$11.27 - $13.53 $202,386 - $242,971
17,958 Added 7.05%
272,700 $3.26 Million
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $612,733 - $758,056
69,867 Added 37.79%
254,742 $2.76 Million
Q3 2023

Nov 01, 2023

BUY
$9.59 - $11.35 $350,552 - $414,887
36,554 Added 24.65%
184,875 $1.82 Million
Q2 2023

Aug 07, 2023

SELL
$9.02 - $10.29 $695,126 - $792,998
-77,065 Reduced 34.19%
148,321 $1.48 Million
Q1 2023

Apr 28, 2023

SELL
$9.2 - $12.26 $115,036 - $153,299
-12,504 Reduced 5.26%
225,386 $2.17 Million
Q4 2022

Feb 10, 2023

BUY
$8.72 - $11.56 $1.86 Million - $2.46 Million
212,830 Added 849.28%
237,890 $2.65 Million
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $62,149 - $81,571
-7,329 Reduced 22.63%
25,060 $214,000
Q2 2022

Jul 20, 2022

BUY
$9.95 - $12.27 $322,270 - $397,413
32,389 New
32,389 $339,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $141,224 - $221,698
-14,396 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$12.09 - $14.68 $174,047 - $211,333
14,396 New
14,396 $195,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1.35 Million - $1.84 Million
-99,239 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1.42 Million - $1.86 Million
99,239 New
99,239 $1.86 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wealthfront Advisers LLC Portfolio

Follow Wealthfront Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.